Pierre studied chemistry at the University of Tübingen (Germany). He received his Ph.D. in 2009 under the supervision of Prof. Stefan Laufer working on the design, synthesis and biological testing of novel small molecule inhibitors of protein kinases. As a postdoctoral fellow, he worked under the direction of Prof. Michael E. Jung at the University of California, Los Angeles (USA) in the Department of Organic Chemistry on the total synthesis of bioactive natural products. In 2012, he moved back to Germany to the group of Prof. Christa E. Müller at the University of Bonn where he worked as a postdoctoral researcher on the development of novel therapeutics for neurodegenerative diseases.
From 2013 until 2020, he was working as assistant professor for medicinal chemistry at the Pharmaceutical Institute of the University of Tübingen. In summer 2018, Pierre successfully finished his habilitation.
From May 2020 until October 2022, he is working as interim chair of the department of Pharmaceutical/Medicinal Chemistry II at the University of Regensburg.
In November 2022, Pierre was appointed as Professor for Pharmaceutical/Medicinal Chemistry at the University of Regensburg and he is chair of the department of Pharmaceutical/Medicinal Chemistry II.
His research interests are in the field of medicinal chemistry and chemical biology.
Pierre received the Neuroallianz Publication Price (silver) in 2014 and was awarded with the Nachwuchspreis der DPhG-Stiftung (Horst-B?hme-Stiftung) in 2018. In 2021, he received the Innovation Award 2021 in Medicinal Chemistry from the division Medicinal Chemistry of the German Chemical Society (GDCh) and the division Pharmaceutical/Medicinal Chemistry of the German Pharmaceutical Society (DPhG). Recently, he was awarded with the Phoenix-Pharmazie Wissenschaftspreis 2022.
